However, only few studies thus far have evaluated the ability of HGB to predict outcomes in localized PCa [13,14].Considering its value in predicting both disease-specific mortality [10] and all-cause mortality [15,16], HGB promises to be a valuable tool to predict the survival of PCa patients. The gene discussed is CYGB; the disease is posterior cortical atrophy.